Variation in the bluetongue virus neutralization protein VP2

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Bluetongue virus (BTV) is a significant arbovirus affecting livestock globally.
• Antigenic variation in BTV, particularly in the outer capsid protein VP2, is a key factor in viral evolution and immune evasion.
• Understanding VP2 sequence variation is crucial for developing effective vaccines and diagnostic tools.

Purpose of the Study:

• To determine the extent and nature of antigenic variation among four U.S.A. serotypes of bluetongue virus (BTV).
• To compare the VP2 protein sequences of BTV serotypes 10, 11, 13, and 17 to identify regions of variability.

Main Methods:

• Complete nucleotide sequencing of cDNA clones representing the L2 dsRNA of BTV serotype 13.
• Comparative analysis of predicted amino acid sequences of VP2 proteins from BTV-10, BTV-11, BTV-13, and BTV-17.
• Utilizing diagon comparisons, hydropathic plots, and secondary structure analyses.

Main Results:

• All four VP2 proteins exhibited structural similarity.
• The VP2 protein of BTV-13 showed only 40% homology with the VP2 proteins of the other three U.S.A. serotypes.
• Specific regions within the VP2 proteins displayed higher variability, consistent with antigenic drift.

Conclusions:

• Significant sequence divergence exists in the VP2 protein among U.S.A. BTV serotypes, particularly for BTV-13.
• The identified variable regions in VP2 are likely responsible for the observed antigenic variation.
• These findings provide insights into BTV's molecular epidemiology and antigenic diversity.